Centessa Pharmaceuticals: A Diversified Bet In Underserved Markets (NASDAQ:CNTA)

Introduction

Founded in October 2020, Centessa Pharmaceuticals (NASDAQ:CNTA) is a clinical-stage firm committed to creating transformative medicines. Utilizing an “asset-centric” approach, the company acquired 11 pre-revenue biotech firms in January 2021 and went public in June 2021. It has

Read the full article here